Sai Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 18.61 Cr
as on 05-07-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,307.73 Cr
as on 05-07-2024
- Satisfied Charges ₹ 1,194.72 Cr
as on 05-07-2024
- Revenue 11.61%
(FY 2022)
- Profit -75.99%
(FY 2022)
- Ebitda -24.79%
(FY 2022)
- Net Worth 2.71%
(FY 2022)
- Total Assets 15.93%
(FY 2022)
About Sai Life Sciences
The Corporate was formerly known as Sai Advantium Pharma Limited Definitions & Interpretation. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 18.61 Cr.
The company currently has active open charges totaling ₹1,307.73 Cr. The company has closed loans amounting to ₹1,194.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sai Life Sciences Limited India are Runa Karan as Company Secretary, Lakshminarayanan Chittor as Cfo, Krishnamraju Kanumuri as Ceo, and One other members. Ranga Kanumuri, Krishnamraju Kanumuri, Puneet Bhatia, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24110TG1999PLC030970
- Company No.
030970
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1999
- Date of AGM
07 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sai Life Sciences Limited offer?
Sai Life Sciences Limited offers a wide range of products and services, including Pharmaceutical Services, Molecular Biology Services, Pharma & Bioanalytical Services, Medicinal Chemistry Services, Formulation Development Service, Life Science Service, Medical Consultancy Services, Microbiology Services.
Who are the key members and board of directors at Sai Life Sciences?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Krishnamraju Kanumuri | Managing Director | 01-May-2004 | Current |
Runa Karan | Company Secretary | 03-Oct-2008 | Current |
Lakshminarayanan Chittor | CFO | 01-Jul-2021 | Current |
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ranga Kanumuri | Whole-Time Director | 25-Jan-1999 | Current |
Puneet Bhatia | Director | 25-Jul-2018 | Current |
Manjusha Joshi | Director | 09-Jun-2023 | Current |
Raju Penmasta | Director | 08-Mar-1999 | Current |
Mitesh Daga | Director | 30-Jul-2018 | Current |
Rajagopal Tatta | Director | 10-Jan-2007 | Current |
Financial Performance and Corporate Structure Insights of Sai Life Sciences.
Sai Life Sciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.61% increase. The company also saw a substantial fall in profitability, with a 75.99% decrease in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Life Sciences?
In 2022, Sai Life Sciences had a promoter holding of 37.95% and a public holding of 62.05%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manipal Health Enterprises Private LimitedActive 14 years 10 months
Puneet Bhatia is a mutual person
- Sai Life Pharma Private LimitedActive 5 years 1 month
Ranga Kanumuri, Krishnamraju Kanumuri and 4 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Sbicap Trustee Company Limited Creation Date: 06 Oct 2023 | ₹768.60 Cr | Open |
Sbicap Trustee Company Limited Creation Date: 06 Oct 2023 | ₹25.00 Cr | Open |
Sbicap Trustee Company Limited Creation Date: 06 Oct 2023 | ₹18.76 Cr | Open |
How Many Employees Work at Sai Life Sciences?
Sai Life Sciences has a workforce of 2845 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.